197 related articles for article (PubMed ID: 29536377)
1. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
Zhang JM; Wei K; Jiang M
Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].
Jiang XD; Luo G; Wang XH; Chen LL; Ke X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):27-33. PubMed ID: 28072991
[No Abstract] [Full Text] [Related]
4. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
5. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
6. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
7. OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2
Yang F; Zhang J; Yang H
Onco Targets Ther; 2018; 11():7873-7881. PubMed ID: 30464534
[TBL] [Abstract][Full Text] [Related]
8. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
9. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
Zeng Z; Chen X; Zhu D; Luo Z; Yang M
Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
[TBL] [Abstract][Full Text] [Related]
10. High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.
Shen L; Huang X; Xie X; Su J; Yuan J; Chen X
J Histochem Cytochem; 2014 Jul; 62(7):499-509. PubMed ID: 24710660
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM
BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
[TBL] [Abstract][Full Text] [Related]
14. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
Basati G; Mohammadpour H; Emami Razavi A
J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
[TBL] [Abstract][Full Text] [Related]
16. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
[TBL] [Abstract][Full Text] [Related]
17. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
18. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy.
Yang S; Zheng J; Ma Y; Zhu H; Xu T; Dong K; Xiao X
Oncol Rep; 2012 Jul; 28(1):186-92. PubMed ID: 22576801
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.
Ge N; Lin HX; Xiao XS; Guo L; Xu HM; Wang X; Jin T; Cai XY; Liang Y; Hu WH; Kang T
J Transl Med; 2010 Oct; 8():94. PubMed ID: 20937145
[TBL] [Abstract][Full Text] [Related]
20. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
